Richard Waugh

Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Are you Richard Waugh?

Claim your profile

Publications (7)14.57 Total impact

  • Article: Large focal nodular hyperplasia and extrahepatic portosystemic shunt in a male patient: multi-modality imaging features.
    [show abstract] [hide abstract]
    ABSTRACT: Congenital extrahepatic portocaval shunt is a rare condition that is described mostly in female patients. We report an unusual case of a young adult male patient with type 1 congenital extrahepatic portocaval shunt with associated development of a focal nodular hyperplasia on a background of regenerative nodules. With multi-slice CT utilisation, there is increased detection of portocaval malformation in asymptomatic patients. This congenital variant is clinically significant with associated development of hepatocellular lesions, hepatic dysfunction and/or encephalopathy.
    Journal of Medical Imaging and Radiation Oncology 10/2011; 55(5):502-5. · 0.87 Impact Factor
  • Article: Doppler-derived pulmonary flow reserve detects pulmonary microvascular obstruction in high primates.
    [show abstract] [hide abstract]
    ABSTRACT: Despite increasing evidence implicating the pulmonary microcirculation in the pathogenesis of lung conditions such as pulmonary vascular disease, there remain few methods for its evaluation in vivo. We recently demonstrated that the novel index of Doppler-derived pulmonary flow reserve (PFR(dopp)=maximal hyperaemic/basal pulmonary flow) could be reliably measured in high primates. Noting that the microvasculature is the chief regulator of pulmonary blood flow, we hypothesised that PFR(dopp) may detect microcirculatory loss. We therefore studied the relationship between PFR(dopp) and experimentally induced pulmonary microvascular obstruction using microspheres in higher primates. Under ketamine anaesthesia, Doppler sensor-guidewires were placed in the segmental pulmonary artery of three adult baboons. Doppler flow velocity and haemodynamics were recorded at rest and during hyperaemia [as induced by intrapulmonary artery adenosine (200 μg/kg/min)]. Serial PFR(dopp) evaluations were made after cumulative intrapulmonary artery ceramic microspheres administration. Cumulative microsphere administration progressively reduced PFR(dopp) (1.54 ± 0.26, 1.48 ± 0.20, 1.12 ± 0.04 and 1.18 ± 0.09; baseline, 10(4), 10(5) and 10(6) microspheres boluses; p<0.02) without affecting pulmonary artery pressure, systemic artery pressure or heart rate. Doppler-derived PFR can detect partial, progressive pulmonary microvascular obstruction in higher primates. PFR(dopp) may thus have a potential role in the assessment of the pulmonary microcirculation in vivo.
    Heart Lung &amp Circulation 10/2010; 19(10):592-4. · 1.20 Impact Factor
  • Source
    Article: Measurement of pulmonary flow reserve and pulmonary index of microcirculatory resistance for detection of pulmonary microvascular obstruction.
    [show abstract] [hide abstract]
    ABSTRACT: The pulmonary microcirculation is the chief regulatory site for resistance in the pulmonary circuit. Despite pulmonary microvascular dysfunction being implicated in the pathogenesis of several pulmonary vascular conditions, there are currently no techniques for the specific assessment of pulmonary microvascular integrity in humans. Peak hyperemic flow assessment using thermodilution-derived mean transit-time (T(mn)) facilitate accurate coronary microcirculatory evaluation, but remain unvalidated in the lung circulation. Using a high primate model, we aimed to explore the use of T(mn) as a surrogate of pulmonary blood flow for the purpose of measuring the novel indices Pulmonary Flow Reserve [PFR = (maximum hyperemic)/(basal flow)] and Pulmonary Index of Microcirculatory Resistance [PIMR = (maximum hyperemic distal pulmonary artery pressure)x(maximum hyperemic T(mn))]. Ultimately, we aimed to investigate the effect of progressive pulmonary microvascular obstruction on PFR and PIMR. Temperature- and pressure-sensor guidewires (TPSG) were placed in segmental pulmonary arteries (SPA) of 13 baboons and intravascular temperature measured. T(mn) and hemodynamics were recorded at rest and following intra-SPA administration of the vasodilator agents adenosine (10-400 microg/kg/min) and papaverine (3-24 mg). Temperature did not vary with intra-SPA sensor position (0.010+/-0.009 v 0.010+/-0.009 degrees C; distal v proximal; p = 0.1), supporting T(mn) use in lung for the purpose of hemodynamic indices derivation. Adenosine (to 200 microg/kg/min) & papaverine (to 24 mg) induced dose-dependent flow augmentations (40+/-7% & 35+/-13% T(mn) reductions v baseline, respectively; p<0.0001). PFR and PIMR were then calculated before and after progressive administration of ceramic microspheres into the SPA. Cumulative microsphere doses progressively reduced PFR (1.41+/-0.06, 1.26+/-0.19, 1.17+/-0.07 & 1.01+/-0.03; for 0, 10(4), 10(5) & 10(6) microspheres; p = 0.009) and increased PIMR (5.7+/-0.6, 6.3+/-1.0, 6.8+/-0.6 & 7.6+/-0.6 mmHg.sec; p = 0.0048). Thermodilution-derived mean transit time can be accurately and reproducibly measured in the pulmonary circulation using TPSG. Mean transit time-derived PFR and PIMR can be assessed using a TPSG and adenosine or papaverine as hyperemic agents. These novel indices detect progressive pulmonary microvascular obstruction and thus have with a potential role for pulmonary microcirculatory assessment in humans.
    PLoS ONE 01/2010; 5(3):e9601. · 4.09 Impact Factor
  • Article: Recombinant activated factor VII for massive hemoptysis in patients with cystic fibrosis.
    [show abstract] [hide abstract]
    ABSTRACT: Massive hemoptysis is a common complication in patients with cystic fibrosis (CF) and is associated with significant morbidity and mortality. Conventional treatment with antibiotic therapy and early bronchial artery embolization (BAE) is usually successful in achieving hemostasis in the majority of patients. Recombinant activated factor VII (rFVIIa), originally developed for use in patients with hemophilia, has emerged as a general hemostatic agent that is potentially useful in the management of many life-threatening bleeding conditions. In this article, we present four patients with CF lung disease and massive hemoptysis who were treated successfully with rFVIIa. We suggest that in patients with CF who present with massive hemoptysis, the use of rFVIIa can be considered in patients with refractory hemoptysis despite conventional therapy or as a temporizing therapy when BAE is not immediately available.
    Chest 08/2009; 136(1):277-81. · 5.25 Impact Factor
  • Article: Measurement of pulmonary flow reserve in higher primates.
    [show abstract] [hide abstract]
    ABSTRACT: 1. There are currently limited diagnostic methods for assessing the integrity of the pulmonary microvasculature. We hypothesized that a novel, invasively determined physiological index of 'pulmonary flow reserve' (PFR = maximal hyperaemic pulmonary blood flow divided by basal pulmonary flow) may facilitate microvascular assessment in the lung. Therefore, we developed a baboon model in which to: (i) validate the use of Doppler flow velocity for PFR assessment; (ii) define the optimal drug and dose regimen for attainment of maximal pulmonary hyperaemia; and (iii) demonstrate the feasibility of measuring PFR in healthy higher primates. 2. Doppler sensor guidewires were placed in segmental pulmonary arteries of 11 ketamine-anaesthetized baboons. Vessel diameter, flow velocity and haemodynamics were recorded before and after direct intrapulmonary artery administration of saline, adenosine (50-500 microg/kg per min) and papaverine (3-60 mg), enabling calculation of PFR. 3. Saline (either bolus injection or infusion) did not alter vessel diameter or flow velocity (P > 0.1), validating local drug administration. Both adenosine and papaverine induced dose-dependent increases in flow velocity from baseline (from 22.5 +/- 2.3 to 32.7 +/- 4.8 cm/s for 400-500 microg/kg per min adenosine; and from 23.9 +/- 1.1 to 34.6 +/- 4.0 cm/s for 24 mg papaverine; both P < 0.0001), without affecting pulmonary artery pressure or vessel diameter (P > 0.3). Healthy primate PFR values were 1.35 +/- 0.10 and 1.39 +/- 0.10 using 200 microg/kg per min adenosine and 24 mg papaverine, respectively (P > 0.8). 4. In conclusion, pulmonary flow reserve in higher primates can be assessed using Doppler sensor guidewire and either adenosine or papaverine as microvascular hyperaemic agents. Measurements of PFR may facilitate pulmonary microvascular assessments.
    Clinical and Experimental Pharmacology and Physiology 02/2009; 36(8):797-802. · 1.85 Impact Factor
  • Article: Screening tests for renal artery stenosis: a case-series from an Australian tertiary referral centre.
    [show abstract] [hide abstract]
    ABSTRACT: Renal artery stenosis is a common, correctable cause of hypertension and renal impairment, with multiple screening tests available to aid diagnosis. Data assessing the accuracy of screening tests are mostly derived from tight 'experimental' protocols and the application of these tests to large-scale clinical practice is not clear. Our aim was to investigate physician preferences and diagnostic accuracy of screening tests for renal artery stenosis when applied to clinical practice in a large, Australian tertiary referral centre. We investigated all renal angiograms performed at our institution between September 2002 and September 2004, as referred by renal physicians. We accessed hospital and physician records of all patients to document demographics, clinical history, screening investigations, source of screening and angiogram results. The series involved 75 consecutive patients who had 79 screening investigations (four patients had two screening tests). The case series showed that 19 (24%) patients did not have any screening investigations prior to angiography. Duplex ultrasonography was the most utilised screening test, being used in 20 (33%) of the remaining 60 screening tests. Computed tomographic angiography (CTA) was used in 19 (32%), magnetic resonance imaging in 13 (22%) and renal scintigraphy was used in four (7%) screening procedures. Magnetic resonance angiography was the most accurate screening test with a positive predictive value of 92%, followed by duplex ultrasonography with 88% and CTA was relatively inaccurate, with a positive predictive value (PPV) of 58% (P = 0.036). Clinical suspicion alone was inaccurate with a PPV of 40%, except in previously treated renal artery stenosis (PPV 89%). Duplex ultrasonography was the most utilised screening investigation amongst the physicians of our referral base. Magnetic resonance angiography and duplex ultrasonography had good positive predictive values, while CTA may not be as reliable as previously reported when applied to a large, non-selective clinical practice.
    Nephrology 03/2006; 11(1):68-72. · 1.31 Impact Factor
  • Article: The Effect of various hearing protectors on sound localization in the horizontal and vertical planes
    William Noble, Narelle Murray, Richard Waugh
    [show abstract] [hide abstract]
    ABSTRACT: Sumario: Listeners were tested under free head/torso movement conditions, using a brief pulsed broadband noise signal presented from any 1 of 20 loudspeakers in two intersecting hemicircumferential arrays: one in the horizontal plane, one in the vertical. Results showed that listeners could accomplish the task successfully in normal (open-ear) conditions